CENTOCOR INC
424B3, 1998-09-24
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: NORWEST FINANCIAL INC, 424B2, 1998-09-24
Next: SHELTER PROPERTIES V LIMITED PARTNERSHIP, SC 14D1/A, 1998-09-24



<PAGE>
 
                                      FILED UNDER RULE 424(b)(3) OF REGULATION C
                                                      SEC FILE NUMBER: 333-53157

PROSPECTUS SUPPLEMENT
(TO PROSPECTUS DATED JULY 2, 1998)


                                 CENTOCOR, INC.

              $460,000,000 PRINCIPAL AMOUNT OF 4 3/4% CONVERTIBLE
                        SUBORDINATED DEBENTURES DUE 2005
                  (INTEREST PAYABLE AUGUST 15 AND FEBRUARY 15)
                     -------------------------------------
                            9,338,015 COMMON SHARES
                           ($.01 PAR VALUE PER SHARE)
                            ------------------------

     The information in this Prospectus Supplement concerning the Selling
Securityholders supplements the statement set forth under the caption "Selling
Securityholders" in the Prospectus, as supplemented on July 9, 1998, July 16,
1998, July 29, 1998, August 4, 1998, August 11, 1998, August 18, 1998, August
24, 1998, September 1, 1998, September 3, 1998, September 15, 1998 and September
21, 1998.  Capitalized terms used and not defined herein shall have the meanings
given to them in the Prospectus.

                            SELLING SECURITYHOLDERS

     The information set forth under the caption "Selling Securityholders" in
the Prospectus, as supplemented on July 9, 1998, July 16, 1998, July 29, 1998,
August 4, 1998, August 11, 1998, August 18, 1998, August 24, 1998, September 1,
1998, September 3, 1998, September 15, 1998, and September 21, 1998, is
supplemented to add the following:

<TABLE>
<CAPTION>
                                                                              NUMBER OF   
                                                                             CONVERSION   
 NAME OF SELLING        AMOUNT OF DEBENTURES          PERCENT OF             SHARES THAT  
SECURITYHOLDER(1)        BENEFICIALLY OWNED      OUTSTANDING DEBENTURES     MAY BE SOLD(2)
- -----------------       --------------------     ----------------------     --------------
<S>                     <C>                      <C>                        <C>           
Arnold H. Simon        
  Family Foundation,   
  Inc.                      $  500,000                   .11%                    10,150 

Credit Suisse          
  First Boston         
  Corporation               $  250,000                   .05%                     5,075
                       
Navesink Equity        
  Derivatives          
  Fund LDC                  $3,000,000                   .65%                    60,900
</TABLE>
 ____________________________

(1)  The information set forth herein is as of September 24, 1998 and will be
     updated as required.

(2)  Assumes conversion of the full amount of Debentures held by such holder at
     the initial conversion price of $49.261 per share of Common Stock.  Under
     the terms of the Indenture, fractional shares will not be issued upon
     conversion of the Debentures; cash will be paid in lieu of any fractional
     shares.

The date of this Prospectus Supplement is September 24, 1998.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission